-1- AIT (VP-SEC) 016E/2019 May 7, 2019 Subject: Management's Discussion and Analysis of Operating Results for Q1-2019 To: The President of The Stock Exchange of Thailand Summary of Operations Q1

-4124 MMS-AC62/004 February 22, 2019 Subject Management discussion on 2018 operating results To The President of Stock Exchange of Thailand For 2018 operating performance, which was audited by the

and analysis for the period ended March 31, 2018 To Director and Manager of the Stock Exchange of Thailand Referring to the submission of the reviewed financial statements for quarter 1/2018 of Wiik

, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

With the case referral from the Stock Exchange of Thailand (SET) and the SEC’s further investigation, it was found that the four offenders, namely (1) Mr. Win Udomrachtavanich, (2) Mr. Ratachai

connected transactions and acquisition of assets, the company is required to disclose the information on transactions to the Stock Exchange of Thailand (SET) and seek shareholders? approval on the

1 Ref: CK-20-0000-AFD(AC)-L-0042 August 14, 2020 Subject: Clarification on Operating Result and Financial Position for the six-month period ended June 30, 2020 Attention: President The Stock Exchange

ที่ บช NO. AC. 04/2019 14 November 2019 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M.K. Real Estate Development

@halcyon.co.th No. CS-2563/003 27 February 2020 Subject: Management Discussion and Analysis for the Year Ended December 31, 2019 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public